Clinical Trials Browser

Phase 2 × OTHER_GOV × Gemcitabine × Clear all

NCT06388720 2025-09-15

IMGeS

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT03101995 2025-05-28

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Phase 2 Recruiting

Uterine Cervical Neoplasms, Renal Insufficiency

NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Phase 2 Active not recruiting

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

NCT02707159 2023-03-08

PACT-ACT-v6

Phase 2 Completed

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

Phase 2 Completed

Testicular Neoplasms

NCT01043172 2018-01-03

A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

NCT00280878 2016-01-15

Rituximab in Combination With Outpatient Therapy for CD20+ Lymphoma

Phase 2 Completed

Lymphoma, Lymphoma, Non-Hodgkin

NCT00163748 2016-01-08

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Phase 2 Completed

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

Nasopharyngeal Carcinoma

NCT00636883 2014-01-22

GEMOX-T

Phase 2 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT01356368 2014-01-22

Customizing

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00532857 2012-01-04

PGH

Phase 2 Completed

Breast Neoplasms

NCT00532623 2011-06-27

Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00532285 2011-06-23

Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer

Phase 2 Terminated

Breast Neoplasms

NCT00452881 2010-10-25

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453115 2010-10-25

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453167 2010-07-12

Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer

Phase 2 Completed

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00563160 2010-07-07

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Phase 2 Unknown

Lung Neoplasms